All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML
To help navigate the exciting content being presented at the EHA2021 Virtual Congress, the AML Hub Steering Committee members have provided their recommendations for the top abstracts to look out for in AML, including both clinical content and disease biology sessions.
EHA2021 abstracts: What’s hot in AML?
If you would like to view the top abstracts to look out for in AML at EHA2021, please download the resource below.Download here
Interim phase II results from the ongoing AG221-AML-005 study on enasidenib plus azacitidine in patients with newly diagnosed acute myeloid leukemia with IDH2 mutations
Enasidenib (ENA) is an oral, small-molecule inhibitor of mutant (m) IDH2 protein...
Subscribe to get the best content related to AML delivered to your inbox